The Insight 46 study has indicated that changes in blood pressure in people as young as 36 may be linked to poorer brain health later in life.
Analysis of large Danish and American datasets suggests that poor air quality may increase the prevalence of neurological and psychiatric disorders.
A blood test for glioblastoma may be on the horizons, as researchers identify novel biomarkers that could be used for diagnosis.
Discover more about an ongoing, multicenter registry that provides real-world evidence regarding ataluren use in nonsense mutation Duchenne muscular dystrophy patients in this research article.
In this Editorial, published in the journal Future Neurology, the author discusses the need for continued funding for spinal muscular atrophy.
In this review article, published in the journal Immunotherapy, the authors explore immunotherapy for neuroblastoma from therapeutic backbone to the latest discoveries.